After the leap: The Pimi Fund and Mivtach Shamir are realizing $ 75 million in Gilat – the capital market
The Pimi Foundation and the Algarbeli family sold about 14% of the drug to institutional investors for NIS 40 million – the capital market
The Pimi Fund acquired 88% of the Rafa pharmaceutical company for NIS 540 million – the capital market
